Angelini Ventures logo

Angelini Ventures

Europe, Lazio, Italy, Rome

Description

Angelini Ventures is an investment firm.

Investor Profile

Angelini Ventures has backed more than 18 startups, with 9 new investments in the last 12 months alone. The firm has led 6 rounds, about 33% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States, Italy, Switzerland.
  • Strong thematic focus on Health Care, Therapeutics, Biotechnology.
  • Led 4 rounds in the past year.

Stage Focus

  • Series A (39%)
  • Series B (17%)
  • Series C (17%)
  • Seed (17%)
  • Pre Seed (6%)
  • Series Unknown (6%)

Country Focus

  • United States (44%)
  • Italy (22%)
  • Switzerland (6%)
  • Belgium (6%)
  • Denmark (6%)
  • Germany (6%)
  • Singapore (6%)
  • France (6%)

Industry Focus

  • Health Care
  • Therapeutics
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Medical Device
  • Neuroscience
  • Health Diagnostics
  • Mobile Devices
  • Wearables
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Angelini Ventures frequently co-invest with?

Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
Asahi Kasei
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 1
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 1
TI
Europe, Bayern, Germany, Munich
Co-Investments: 2
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
AW
North America, Florida, United States, Miami
Co-Investments: 1
Bayern Kapital
Europe, Bayern, Germany, Landshut
Co-Investments: 2
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1

Which angels does Angelini Ventures often collaborate with?

AC
Europe, Lombardia, Italy, Milan
Shared Deals: 1

What are some of recent deals done by Angelini Ventures?

Laigo Bio

Utrecht, Utrecht, The Netherlands

Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders.

BiotechnologyMedical
SeedDec 3, 2025
Amount Raised: $13,406,842
CoMind

London, England, United Kingdom

CoMind is a noninvasive neural technology company building next-generation neural interfaces.

Artificial Intelligence (AI)HardwareMachine LearningNeuroscienceSoftware
Series AOct 20, 2025
Amount Raised: $60,000,000
Adcytherix

Marseille, Provence-Alpes-Cote d'Azur, France

Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).

BiotechnologyOncology
Series AOct 16, 2025
Amount Raised: $122,438,699
Serenis Health

Milan, Lombardia, Italy

Serenis is a mental health platform that provides psychotherapy with a strong focus on science & impact measurement

Health CareMental Health
Series ASep 29, 2025
Nuclidium

Basel, Basel-Stadt, Switzerland

Nuclidium is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics.

Health CareHealth DiagnosticsMedicalTherapeutics
Series BJul 10, 2025
Amount Raised: $99,518,156
Elkedonia

Strasbourg, Alsace, France

Elkedonia is a biotech company dedicated to transforming antidepressant therapy.

BiotechnologyHealth CareMedical
SeedJun 11, 2025
Amount Raised: $12,842,202
Therini Bio

San Francisco, California, United States

Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.

BiotechnologyHealth CareMedicalTherapeutics
Series AMay 14, 2025
Amount Raised: $39,000,000
Nuevocor

Singapore, Central Region, Singapore

Nuevocor operates as a preclinical-stage biotech company.

BiopharmaBiotechnologyMedicalPharmaceutical
Series BMay 6, 2025
Amount Raised: $45,000,000
Biovitae

Salerno, Campania, Italy

Biovitae focuses on infection control and prevention, as well as combating antimicrobial resistance.

Health CareHealth DiagnosticsTherapeutics
Series AApr 22, 2025
Amount Raised: $5,675,478
Vantis Vascular

San Jose, California, United States

Vantis Vascular develops technology for vascular interventions targeting complex arteries.

AppsHealth CareInformation TechnologyMedicalMedical Device
Series UnknownMar 12, 2025
Amount Raised: $10,885,681

Find More Investors Like Angelini Ventures

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Angelini Ventures | Pipeseed